Brief: Rand Capital Portfolio Company, Rheonix Inc., To Launch Rapid, Fully Automated Coronavirus Disease 2019 (Covid-19) Assay
March 19 (Reuters) - Rand Capital Corp RAND.O :
* RAND CAPITAL PORTFOLIO COMPANY, RHEONIX INC., TO LAUNCH
RAPID,
FULLY AUTOMATED CORONAVIRUS DISEASE 2019 (COVID-19) ASSAY
* RAND CAPITAL - RHEONIX ANTICIPATES SUBMITTING EUA TO FDA
ON
RHEONIX COVID-19 MDX ASSAY FOR DETECTION OF SARS-COV-2 AS SOON
AS VALIDATION IS COMPLETE
Source text for Eikon: ID:nBw6N3NFba
Further company coverage: RAND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rand Capital
See all newsRand Capital Q2 investment income falls on non-accruals
Rand Capital Q4 investment income falls 40% due to portfolio repayments
Rand Capital Q3 total investment income falls 29% on portfolio repayments
Brief: Rand Capital Corporation Q2 Dividend USD 0.29
Brief: Rand Capital Announces Portfolio Company SciAps to be Acquired by Spectris plc